Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Andrea Corona Altimmunes GLP-1 drug shows positive results for alcohol use disorder On Tuesday, Altimmune announced topline data from their Phase 2 RECLAIM trial showing that pemvidutide, an investigational balanced glucagon/GLP-1 dual receptor agonist, significantly reduced the number of heavy drinking days compared to placebo in patients with moderate to severe alcohol use disorder
Both peptides have proven healing and regenerative effects, from which it follows that they share potential applications in speeding up injury recovery, too
DSIP is researched for its recognized therapeutic potential, which include observed benefits like: Increasing sleep quality Reducing anxiety Stress reduction These effects make DSIP an important compound in sleep and psychiatric studies
Epigenetic signatures: NNMT expression changes observed in human adipose tissue
2019;32(6):e100144
In animal and cell culture studies, GHK-Cu stimulates the proliferation of dermal papilla cells, the structures at the base of each hair follicle that govern its growth cycle
US$ 22.62
US$ 21.22
US$ 24.16
US$ 21.84
US$ 25.65
US$ 25.59
US$ 26.78
